Pegcetacoplan
ATC L04AJ03 · 6 markets · 12 records
AU 5 records · 4 strengths
- 1,080 mg/20 mLinjectionEmpaveli
- 1,080 mginjectionEMPAVELI pegcetacoplan 1080 mg/20 mL injection solution vial
- 15 mginjectionSYFOVRE pegcetacoplan 15 mg/0.1 mL solution for injection vial
Records without a stated strength · 1 Empaveli、Syfovre
US 2 records · 2 strengths
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 ASPAVELI、Syfovre
GB 1 records · 1 strengths
- 1,080 mg/20 mLinjectionAspaveli 1080mg/20ml solution for infusion vials
CA 1 records · 1 strengths
- 54 mg/1 mLliquidEmpaveli
ES 1 records · 1 strengths
- 1,080 mginjectionASPAVELI
| Strength / form / release | US | GB | CA | AU | ES | EU |
|---|---|---|---|---|---|---|
| 1,080 mg/20 mLRecorded as: 1.08 g/20 mL injection | Empaveli | Aspaveli 1080mg/20ml solution for infusion vials | Empaveli | |||
| 1,080 mg injection | EMPAVELI pegcetacoplan 1080 mg/20 mL injection solution vial | ASPAVELI | ||||
| 54 mg/1 mL liquid | Empaveli | |||||
| 15 mg/0.1 mL injection | Syfovre | |||||
| 15 mg injection | SYFOVRE pegcetacoplan 15 mg/0.1 mL solution for injection vial | |||||
unknown | Empaveli Syfovre | ASPAVELI Syfovre |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.